- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
Clear All
19 Schizophrenia Trials near Chicago, IL
Power is an online platform that helps thousands of Schizophrenia patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerKarXT for Schizophrenia
Trial Details
Key Eligibility Criteria
280 Participants Needed
SEP-363856 for Schizophrenia
Trial Details
Key Eligibility Criteria
522 Participants Needed
Digital Therapeutics for Schizophrenia
Trial Details
Key Eligibility Criteria
432 Participants Needed
OLZ/SAM vs. Olanzapine for Schizophrenia or Bipolar Disorder
Trial Details
Key Eligibility Criteria
220 Participants Needed
OLZ/SAM for Schizophrenia
Trial Details
Key Eligibility Criteria
236 Participants Needed
Clozapine vs Risperidone for Psychosis
Trial Details
Key Eligibility Criteria
524 Participants Needed
Emraclidine for Schizophrenia
Trial Details
Key Eligibility Criteria
850 Participants Needed
ALTO-101 for Schizophrenia
Trial Details
Key Eligibility Criteria
82 Participants Needed
Coordinated Specialty Care for Psychosis
Trial Details
Key Eligibility Criteria
180 Participants Needed
KarXT for Schizophrenia
Trial Details
Key Eligibility Criteria
360 Participants Needed
Long-term Safety of Iclepertin for Schizophrenia
Trial Details
Key Eligibility Criteria
1361 Participants Needed
SEP-363856 for Schizophrenia
Trial Details
Key Eligibility Criteria
67 Participants Needed
TV-44749 for Schizophrenia
Trial Details
Key Eligibility Criteria
675 Participants Needed
Cariprazine for Pediatric Schizophrenia
Trial Details
Key Eligibility Criteria
310 Participants Needed
Valbenazine for Schizophrenia
Trial Details
Key Eligibility Criteria
442 Participants Needed
LB-102 for Schizophrenia
Trial Details
Key Eligibility Criteria
350 Participants Needed
Brilaroxazine for Schizophrenia
Trial Details
Key Eligibility Criteria
690 Participants Needed
Dexmedetomidine for Agitation in Schizophrenia and Bipolar Disorder
Trial Details
Key Eligibility Criteria
450 Participants Needed
ABBV-932 for Generalized Anxiety Disorder
Trial Details
Key Eligibility Criteria
72 Participants Needed
Why Other Patients Applied
"I really would love to be normal. A functioning part of society. It is very hard to hold a job with this condition. I need to be steady. I do NOT like my current meds or ones I've tried before, so new therapies are of interest to me. "
"I'm willing to try anything to help improve and manage my schizophrenia in any way. I do my best each day to keep the hallucinations at bay. I no longer hear voices but I don't want them to come back either. Most medicine I've tried hasn't help very much."
"I’ve been treated over the years from my late teens. I’ve been through many therapists for my bipolar and my anxiety. None of it’s helped. I gave up when I was 27. It’s been 5 years of struggling day by day. My fiancé has finally suggested I look into trying to get help so I’m hoping this clinical trial will help."
"My psychosis has been manageable for the past few years since I found an antipsychotic that works okay but I still struggle with a lot of mind fog and memory issues. I haven't heard of a treatment for those symptoms until learning about new research so I'm hoping to join a trial to get access."
"I've tried many medications that didn't work that well. I really really want to be better and function in society... a different kind of treatment could help."
Know someone looking for new options?
Spread the word
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.